A Phase Ib/II open-label study to evaluate the safety and efficacy of MEDI-551 in combination with immunomodulating therapy in patients with relapsed or refractory aggressive B cell lymphomas

Trishna Goswami; Paola Canelos; Radhika Parikh

doi:10.1186/2051-1426-2-s3-p73

A Phase Ib/II open-label study to evaluate the safety and efficacy of MEDI-551 in combination with immunomodulating therapy in patients with relapsed or refractory aggressive B cell lymphomas

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-2-s3-p73 ◽

2014 ◽

Vol 2 (S3) ◽

Cited By ~ 1

Author(s):

Trishna Goswami ◽

Paola Canelos ◽

Radhika Parikh

Keyword(s):

B Cell ◽

B Cell Lymphomas ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Phase Ib ◽

Immunomodulating Therapy

Download Full-text

A phase Ib/II open-label study to evaluate the safety and efficacy of TRU-016 in combination with bendamustine versus bendamustine alone in patients with relapsed chronic lymphocytic leukemia.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e13053 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e13053-e13053

Author(s):

F. T. Awan ◽

J. M. Pagel ◽

A. Goy ◽

R. M. Rifkin ◽

B. J. Poiesz ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Lymphocytic Leukemia ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Phase Ib

Download Full-text

A phase 1b/2, open-label study to evaluate the safety and tolerability of MEDI6469 in combination with immune therapeutic agents or therapeutic mAbs in patients with selected advanced solid tumors or aggressive B-cell lymphomas.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps3091 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS3091-TPS3091 ◽

Cited By ~ 3

Author(s):

John D. Powderly ◽

Martin Gutierrez ◽

Ding Wang ◽

Young Kwang Chae ◽

Daruka Mahadevan ◽

...

Keyword(s):

B Cell ◽

Solid Tumors ◽

Therapeutic Agents ◽

Advanced Solid Tumors ◽

B Cell Lymphomas ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase 1B

Download Full-text

A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis

Arthritis Research & Therapy ◽

10.1186/s13075-014-0415-2 ◽

2014 ◽

Vol 16 (4) ◽

Cited By ~ 9

Author(s):

Maria Greenwald ◽

Leszek Szczepanski ◽

Alastair Kennedy ◽

Melissa Veenhuizen ◽

Wendy J Komocsar ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

B Cell ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

B Cell Activating Factor

Download Full-text

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Case Medical Research ◽

10.31525/ct1-nct03977792 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Labialis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Recurrent Herpes ◽

Cold Sores

Download Full-text

An Open-label Study of the Safety and Efficacy of Tag-7 Gene-modified Tumor Cell-based Vaccine in Patients With Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

Case Medical Research ◽

10.31525/ct1-nct04180774 ◽

2019 ◽

Author(s):

Keyword(s):

Malignant Melanoma ◽

Tumor Cell ◽

Renal Cell ◽

Cell Cancer ◽

Locally Advanced ◽

Metastatic Malignant Melanoma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Faculty of 1000 evaluation for Phase II Open Label Study of the oral VEGF-Receptor inhibitor PTK787/ZK222584 (Vatalanib) in Adult Patients with Refractory or Relapsed Diffuse Large B Cell Lymphoma.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717995403.793474246 ◽

2013 ◽

Author(s):

Nicolas Mounier

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Vegf Receptor ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Large B Cell Lymphoma ◽

Large B Cell ◽

Receptor Inhibitor

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725336183.793540487 ◽

2017 ◽

Author(s):

Lori Ann Birder

Keyword(s):

Overactive Bladder ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Post Marketing

Download Full-text

Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

Journal of Bone and Mineral Research ◽

10.1002/jbmr.4274 ◽

2021 ◽

Author(s):

Sofia Ish‐Shalom ◽

Yoseph Caraco ◽

Nariman Saba Khazen ◽

Michal Gershinsky ◽

Auryan Szalat ◽

...

Keyword(s):

Parathyroid Hormone ◽

Human Parathyroid Hormone ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access (EA) and Commercial out-of-Specification (OOS) Product

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00524-8 ◽

2021 ◽

Vol 27 (3) ◽

pp. S408

Author(s):

Caron A. Jacobson ◽

Frederick L. Locke ◽

David B. Miklos ◽

Julie M. Vose ◽

Yi Lin ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Expanded Access ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Cited By ~ 42

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text